Randomized phase II trial reporting overall survival advantage by adding local consolidative therapy to systemic therapy for oligometastatic non-small cell lung cancer: another step forward on the long road of evidence-based medicine for oligometastatic disease

一项随机II期试验报告称，在寡转移性非小细胞肺癌的全身治疗中加入局部巩固治疗可提高总生存期：这是寡转移性疾病循证医学漫长道路上的又一进步。